There are many innovations concerning the two branches of interventional cardiology. Coronary intervention focuses, especially in young patients, on bio-absorbable stents. Concerning structural heart disease intervention, there seems to be a new worldwide trend, particularly in patients with valvular heart disease, to be treated with percutaneous intervention.
There are many innovations concerning the two branches of interventional cardiology. Coronary intervention focuses, especially in young patients, on bio-absorbable stents. Concerning structural heart disease intervention, there seems to be a new worldwide trend, particularly in patients with valvular heart disease, to be treated with percutaneous intervention.
Professor Emeritus of Cardiology, University of Catania, General Director and Head of Thoracovascular, Morgagni Heart Center, Catania
Disease: Coronary disease , Aortic valve (stenosis) , Mitral valve insufficiency
Specialties: Cardiology , Interventional Cardiology
Tags: Angioplasty , DES (Drug Eluting Stent) , Bioadsorbible Coronary Stent , TAVI (Transcatheter Aortic Valve Implantation)
JIM 2013 - Joint Interventional Meeting
The focus is on structural heart problems
Innovations in interventional cardiology
What has changed in interventional cardiology in the USA
IVUS vs. FFR: which is the best tool for assessment
How to deal with the limitations of drug eluting stents
Hemodynamics: multidisciplinary evolution
Lower limb arterial disease:the drug eluting balloon
Scientific Societies: optimisation of economic resources
Coronary & Vascular interventional cardiology
Structural interventional cardiology
Cerebral protection during valve implantation
Artic stenosis: new devices
Mitral regurgitation: new percutaneous techniques